Difference between revisions of "BioNLP 2023"

From ACL Wiki
Jump to navigation Jump to search
Line 458: Line 458:
 
  * Yuhao Zhang, Stanford University
 
  * Yuhao Zhang, Stanford University
 
  * Wei Zhu, East China Normal University, Shanghai -->
 
  * Wei Zhu, East China Normal University, Shanghai -->
earch in languages other than English
 
 
  
 
===Organizers===
 
===Organizers===

Revision as of 22:28, 20 November 2021

SIGBIOMED

BIONLP 2022 @ ACL 2022


Submission Types & Requirements

Following the previous conferences, BioNLP 2022 will be open for two types of submissions: long and short papers. Please follow ACL guidelines https://acl-org.github.io/ACLPUB/formatting.html and templates: https://github.com/acl-org/ACLPUB/tree/master/templates


WORKSHOP OVERVIEW AND SCOPE

The BioNLP workshop associated with the ACL SIGBIOMED special interest group has established itself as the primary venue for presenting foundational research in language processing for the biological and medical domains. Despite, or maybe due to reaching maturity, the field of Biomedical NLP continues getting stronger. BioNLP welcomes and encourages inclusion and diversity. BioNLP truly encompasses the breadth of the domain and brings together researchers in bio- and clinical NLP from all over the world. The workshop will continue presenting work on a broad and interesting range of topics in NLP.

BioNLP 2022 will be particularly interested in work on detection and mitigation of bias, BioNLP research in languages other than English, particularly, under-represented languages, and health disparities.

Other active areas of research include, but are not limited to:

  • Entity identification and normalization (linking) for a broad range of semantic categories;
  • Extraction of complex relations and events;
  • Discourse analysis;
  • Anaphora/coreference resolution;
  • Text mining / Literature based discovery;
  • Summarization;
  • Τext simplification;
  • Question Answering;
  • Resources and strategies for system testing and evaluation;
  • Infrastructures and pre-trained language models for biomedical NLP / Processing and annotation platforms;
  • Development of synthetic data;
  • Translating NLP research into practice;
  • Getting reproducible results.


Organizers

  Dina Demner-Fushman, US National Library of Medicine
  Kevin Bretonnel Cohen, University of Colorado School of Medicine
  Sophia Ananiadou, National Centre for Text Mining and University of Manchester, UK
  Jun-ichi Tsujii, National Institute of Advanced Industrial Science and Technology, Japan and University of Manchester, UK


Dual submission policy

Papers may NOT be submitted to the BioNLP 2021 workshop if they are or will be concurrently submitted to another meeting or publication.